Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NuVision Biotherapies

NuVision Biotherapies
2014 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$1.71M LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of ophthalmic therapies designed to address key clinical challenges and provide solutions to sight-saving problems. The company has developed a wound-healing therapy that harnesses the regenerative properties of amniotic tissue, which is found in the sac surrounding babies in the womb and is normally discarded at birth, to prevent sight loss, enabling patients to get high quality and affordable biotherapies for treating the front of the eye disease and trauma.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • MediCity, D6 Building, Thane Road
  • Nottingham NG90 6BH
  • England, United Kingdom

+44 0115 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore NuVision Biotherapies’s full profile, request a free trial.

NuVision Biotherapies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 13-Sep-2019 $1.71M 000 Completed Generating Revenue
3. Grant 00.000 00.000 Completed Generating Revenue
2. Early Stage VC 08-Feb-2018 $698K $1.29M Completed Generating Revenue
1. Seed Round 31-Jul-2015 $591K $591K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

NuVision Biotherapies Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
BioCity Venture Capital Minority 000 0000 000000 0
The University of Nottingham Endowment Limited Partner 000 0000 000000 0
Mercia Asset Management Venture Capital Minority 000 0000 000000 0
European Regional Development Fund Other 000 0000 000000 0

NuVision Biotherapies Executive Team (8)

Name Title Board
Seat
Contact
Info
Andrew Hopkinson Ph.D Co-Founder, Chief Executive Officer & Board Member
Harminder Dua Co-Founder and Board Member
Peter Dines Executive Director
Helen Shaw Co-Founder and Co-Chairman
Mark Treherne Ph.D Co-Chairman

3 Former Executives

You’re viewing 5 of 8 executives. Get the full list »

NuVision Biotherapies Board Members (7)

Name Representing Role Since Contact
Info
Andrew Hopkinson Ph.D NuVision Biotherapies Co-Founder, Chief Executive Officer & Board Member 000 0000
Caroline Sykes NuVision Biotherapies Board Member 000 0000
Harminder Dua NuVision Biotherapies Co-Founder and Board Member 000 0000
Helen Shaw Self Co-Founder and Co-Chairman 000 0000
Mark Treherne Ph.D Self Co-Chairman 000 0000
You’re viewing 5 of 7 board members. Get the full list »